Literature DB >> 2680568

Plasmodium vivax interaction with the human Duffy blood group glycoprotein: identification of a parasite receptor-like protein.

S P Wertheimer1, J W Barnwell.   

Abstract

The interaction between merozoites of the human pathogen, Plasmodium vivax, and the Duffy blood group glycoprotein on the surface of human erythrocytes is essential for the invasion of erythrocytes and the survival of the parasite. We have identified a P. vivax protein of 135 to 140 kDa which binds with receptor-like specificity to the human Duffy blood group glycoprotein. This interaction can be specifically inhibited by purified Duffy glycoprotein and by pretreating erythrocytes with a monoclonal antibody directed against a novel Duffy determinant. A protein with similar specificity for the Duffy glycoprotein from the phylogenetically related simian malaria, P. knowlesi, is shown to be immunologically related by the generation of cross-reactive antibodies. Despite their shared properties, these two Duffy associating proteins from P. vivax and P. knowlesi differ in some aspects of their interaction with the Duffy glycoprotein. The identification of these proteins will help elucidate the molecular mechanisms of erythrocyte invasion by Plasmodium.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2680568     DOI: 10.1016/0014-4894(89)90083-0

Source DB:  PubMed          Journal:  Exp Parasitol        ISSN: 0014-4894            Impact factor:   2.011


  81 in total

1.  Two conserved amino acid motifs mediate protein targeting to the micronemes of the apicomplexan parasite Toxoplasma gondii.

Authors:  M Di Cristina; R Spaccapelo; D Soldati; F Bistoni; A Crisanti
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

2.  Antibody responses and avidity of naturally acquired anti-Plasmodium vivax Duffy binding protein (PvDBP) antibodies in individuals from an area with unstable malaria transmission.

Authors:  Sedigheh Zakeri; Laleh Babaeekhou; Akram Abouie Mehrizi; Maryam Abbasi; Navid Dinparast Djadid
Journal:  Am J Trop Med Hyg       Date:  2011-06       Impact factor: 2.345

Review 3.  Malaria vaccine clinical trials: what's on the horizon.

Authors:  Alberto Moreno; Chester Joyner
Journal:  Curr Opin Immunol       Date:  2015-07-13       Impact factor: 7.486

Review 4.  Red blood cell polymorphism and susceptibility to Plasmodium vivax.

Authors:  Peter A Zimmerman; Marcelo U Ferreira; Rosalind E Howes; Odile Mercereau-Puijalon
Journal:  Adv Parasitol       Date:  2013       Impact factor: 3.870

Review 5.  The apicomplexan glideosome and adhesins - Structures and function.

Authors:  Lauren E Boucher; Jürgen Bosch
Journal:  J Struct Biol       Date:  2015-03-09       Impact factor: 2.867

6.  Natural variation within the principal adhesion domain of the Plasmodium vivax duffy binding protein.

Authors:  T Tsuboi; S H Kappe; F al-Yaman; M D Prickett; M Alpers; J H Adams
Journal:  Infect Immun       Date:  1994-12       Impact factor: 3.441

7.  Identification and expression of maebl, an erythrocyte-binding gene, in Plasmodium gallinaceum.

Authors:  Criseyda Martinez; Timothy Marzec; Christopher D Smith; Lisa A Tell; Ravinder N M Sehgal
Journal:  Parasitol Res       Date:  2012-12-07       Impact factor: 2.289

8.  Broadly neutralizing epitopes in the Plasmodium vivax vaccine candidate Duffy Binding Protein.

Authors:  Edwin Chen; Nichole D Salinas; Yining Huang; Francis Ntumngia; Manolo D Plasencia; Michael L Gross; John H Adams; Niraj Harish Tolia
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-18       Impact factor: 11.205

9.  Role of Plasmodium vivax Duffy-binding protein 1 in invasion of Duffy-null Africans.

Authors:  Karthigayan Gunalan; Eugenia Lo; Jessica B Hostetler; Delenasaw Yewhalaw; Jianbing Mu; Daniel E Neafsey; Guiyun Yan; Louis H Miller
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-17       Impact factor: 11.205

Review 10.  Finding the sweet spots of inhibition: understanding the targets of a functional antibody against Plasmodium vivax Duffy binding protein.

Authors:  Francis B Ntumngia; Christopher L King; John H Adams
Journal:  Int J Parasitol       Date:  2012-10-12       Impact factor: 3.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.